UK pharmaceuticals company Indivior gave investors a bitter pill to swallow this morning, as it announced a [...]
Shares in FTSE 250 drugmaker Indivior dropped today after the firm said it was forced to set more money aside [...]
GlaxoSmithKline (GSK) today announced it has launched a lawsuit against US-based Gilead Sciences over alleged [...]
FTSE 250 drugmaker Indivior has partnered with Swiss firm Addex Therapeutics to develop drugs to combat alcohol [...]
Drugmaker Indivior's shares got a fresh boost this morning after the US Food and Drug Administration (FDA) announced [...]
Shares in drugmaker Indivior jumped today after the company announced a US Food and Drug Administration (FDA) [...]
FTSE 250 drugmaker Indivior is gearing up to appeal a US court ruling that said a proposed generic version [...]
FTSE-250 drug company Indivior's full-year pre-tax profits have taken a beating from a $220m (£176m) litigation [...]
Shares at Indivior crumbled during yesterday’s trade but recovered to be down only 2.4 per cent.
Content tagged with "Indivior"